Etofibrate is a fibrate drug that functions as a peroxisome proliferator-activated receptor alpha (PPARα) agonist, primarily used to treat hypertriglyceridemia by lowering serum triglyceride levels. This… Read more
Etofibrate is a fibrate drug that functions as a peroxisome proliferator-activated receptor alpha (PPARα) agonist, primarily used to treat hypertriglyceridemia by lowering serum triglyceride levels. This compound, a combination of clofibrate and niacin linked by an ester bond, works by upregulating lipoprotein lipase activity and enhancing fatty acid oxidation. This category provides essential tools for pharmaceutical analysis, offering reference standards for the Etofibrate active pharmaceutical ingredient, alongside its related pharmacopeial and non-pharmacopeial impurities. These compounds, including metabolites and stable isotope-labelled versions, are critical for rigorous impurity profiling, method validation, and ongoing quality control during drug development and manufacturing. By utilizing these high-quality materials, analytical chemists can ensure accurate identification and quantification of related substances, supporting compliance with regulatory standards throughout the lifecycle of the drug product.